Clinical study to compare the efficacy and safety of casirivimab & imdevimab, remdesivir, and favipravir in hospitalized COVID-19 patients

BACKGROUND: Corona Virus disease - 2019 (COVID-19) disease induces scientific research to find a control to this pandemic from 2020 year up to now. Recently, various advances in pharmacotherapy against COVID-19 have emerged. OBJECTIVES: To compare the efficacy and safety of antibodies cocktail (casi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hegazy, Sahar K., Tharwat, Samar, Hassan, Ahmed H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169321/
https://www.ncbi.nlm.nih.gov/pubmed/37220480
http://dx.doi.org/10.1016/j.jcvp.2023.100151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169321/
https://www.ncbi.nlm.nih.gov/pubmed/37220480
http://dx.doi.org/10.1016/j.jcvp.2023.100151

Ejemplares similares